Dr. Melissa M. Camouse, DO

Dr. Camouse practices at Gardena Dermatology in El Segundo, California.

Dr. Camouse's NPI, 1689885279, was assigned on May 24, 2007. Dr. Camouse graduated from LECOM - Erie in 2002. Dr. Camouse holds California license 20A 9923.

Dr. Camouse's primary practice is Gardena Dermatology, at 713 N Douglas St, El Segundo, CA 90245 in Los Angeles County. The practice phone is (310) 906-2788.

Dr. Camouse's primary practice is Gardena Dermatology in El Segundo, California. Dr. Camouse is also affiliated with Torrance Memorial Medical Center. The medical group on file is El Segundo Dermatology. Dmand AI also links Dr. Camouse to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Camouse practices, 3 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Camouse's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Camouse is board certified in dermatology by the AOA Board of Dermatology. Dr. Camouse is licensed in California.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, cold sores or genital herpes, contact dermatitis, corns and calluses, facial skin infection and hives among the conditions Dr. Camouse treats.

CMS data shows 22,238 Medicare services from Dr. Camouse across 22 procedure codes in 2024, for 1,434 Medicare patients. Medicare paid $443,361 for them. Every service was in an office.

CMS counts 1,434 Medicare patients who saw Dr. Camouse in 2024. The largest group is 65 to 74, with 735 patients. 75% of them have high cholesterol, and 65% have high blood pressure. 13% are also on Medicaid. Their average risk score is 0.98, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Camouse's median patient age at 52, with 62% women.

In 2024, Dr. Camouse wrote 480 Medicare Part D claims for 231 patients. 90% of them were for generic drugs. CMS names the drug for 382 of them, across 14 drugs with 11 or more claims each, at $107,468 in total drug cost. In 2023, CMS named 333 claims across 14 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Camouse for performance year 2024, reported individually. Dr. Camouse accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 2,409 procedures of removal of skin lesions by Dr. Camouse, more than 98% of the clinicians it reports for that procedure.

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 10 papers to Dr. Camouse, published from 2006 to 2010. The most frequent topics are Skin, Prednisone and Cell Proliferation. Dr. Camouse's most frequent co-authors are Seth R. Stevens, MD, Elma D. Baron, MD and Edward Patrick Conrad, MD.

CMS Open Payments shows 256 general payments to Dr. Camouse from 36 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 93% of the total. Galderma Laboratories, L.P. paid the most, $555.

Dmand AI lists 3 awards for Dr. Camouse, most recently CMS Stage 1 EHR in 2013.

Dr. Camouse graduated from LECOM - Erie in 2002. Dr. Camouse is a member of AAD, AOA, American Osteopathic College of Dermatology and American Society for Mohs Surgery.

Dr. Camouse is in network with 17 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.